Syngenta Group Reports Q1 2026 Sales of $6.4 Billion and EBITDA Margin Expansion to 21.9% Across All Four Business Units
Syngenta Group reported Q1 2026 sales of $6.4 billion, a 2% increase from $6.3 billion in Q1 2025 (-4% at constant exchange rates), with growth across all four business units despite a market environment shaped by geopolitical uncertainty and trade disruption.